{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T21:31:24Z","timestamp":1784842284163,"version":"3.55.0"},"reference-count":96,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011892","name":"Kaohsiung Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Hypoxia-inducible factor-prolyl hydroxylase inhibitors (HIF-PHIs) emerge as promising agents to treat anemia in chronic kidney disease (CKD) but the major concern is their correlated risk of cancer development and progression. The Wilms\u2019 tumor gene, <jats:italic>WT1<\/jats:italic>, is transcriptionally regulated by HIF and is known to play a crucial role in tumorigenesis and invasiveness of certain types of cancers. From the mechanism of action of HIF\u2013PHIs, to cancer hypoxia and the biological significance of WT1, this review will discuss the link between HIF, WT1, anemia correction, and cancer. We aimed to reveal the research gaps and offer a focused strategy to monitor the development and progression of specific types of cancer when using HIF\u2013PHIs to treat anemia in CKD patients. In addition, to facilitate the long-term use of HIF\u2013PHIs in anemic CKD patients, we will discuss the strategy of WT1 inhibition to reduce the development and progression of cancer.<\/jats:p>","DOI":"10.3389\/fcell.2022.876723","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T06:20:03Z","timestamp":1649226003000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["WT1: The Hinge Between Anemia Correction and Cancer Development in Chronic Kidney Disease"],"prefix":"10.3389","volume":"10","author":[{"given":"Wen-Chin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Hua","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Huei","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Shu","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.ekir.2021.04.003","article-title":"Phase 3 Study of Roxadustat to Treat Anemia in Non-dialysis-dependant CKD","volume":"6","author":"Akizawa","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"B2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000502012","article-title":"Iron Regulation by Molidustat, a Daily Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, in Patients with Chronic Kidney Disease","volume":"143","author":"Akizawa","year":"2019","journal-title":"Nephron"},{"key":"B3","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1159\/000508100","article-title":"A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Na\u00efve Chronic Kidney Disease Patients Not on Dialysis","volume":"144","author":"Akizawa","year":"2020","journal-title":"Nephron"},{"key":"B4","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/cam4.244","article-title":"Prognostic Significance of Specific Anti\u2010 WT 1 IgG Antibody Level in Plasma in Patients with Ovarian Carcinoma","volume":"3","author":"Andersson","year":"2014","journal-title":"Cancer Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/BF02977473","article-title":"Inhibitory Effect of Curcumin onWT1 Gene Expression in Patient Leukemic Cells","volume":"29","author":"Anuchapreeda","year":"2006","journal-title":"Arch. Pharm. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1681\/ASN.2011111078","article-title":"Mechanisms of Anemia in CKD","volume":"23","author":"Babitt","year":"2012","journal-title":"Jasn"},{"key":"B7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1177\/1091581817737232","article-title":"Evaluation of the Carcinogenic Potential of Roxadustat (FG-4592), a Small Molecule Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase in CD-1 Mice and Sprague Dawley Rats","volume":"36","author":"Beck","year":"2017","journal-title":"Int. J. Toxicol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3233\/DMA-2011-0822","article-title":"WT1 Expression as an Independent Marker of Poor Prognosis in Colorectal Cancers","volume":"8","author":"Bejrananda","year":"2011","journal-title":"Cbm"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1681\/ASN.2010010116","article-title":"Inhibition of Prolyl Hydroxylases Increases Erythropoietin Production in ESRD","volume":"21","author":"Bernhardt","year":"2010","journal-title":"Jasn"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1476-4598-12-3","article-title":"The Wilms' Tumor Gene (WT1) Regulates E-Cadherin Expression and Migration of Prostate Cancer Cells","volume":"12","author":"Brett","year":"2013","journal-title":"Mol. Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0092-8674(90)90601-a","article-title":"Isolation and Characterization of a Zinc finger Polypeptide Gene at the Human Chromosome 11 Wilms' Tumor Locus","volume":"60","author":"Call","year":"1990","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41416-018-0191-x","article-title":"Transcription Factors WT1 and P53 Combined: a Prognostic Biomarker in Ovarian Cancer","volume":"119","author":"Carter","year":"2018","journal-title":"Br. J. Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.aprim.2017.09.007","article-title":"Anemia en la enfermedad renal cr\u00f3nica: protocolo de estudio, manejo y derivaci\u00f3n a Nefrolog\u00eda","volume":"50","author":"Cases","year":"2018","journal-title":"Atenci\u00f3n Primaria"},{"key":"B14","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s12094-013-1146-6","article-title":"Expression of Wilms' Tumor Gene (WT1) Is Associated with Survival in Malignant Pleural Mesothelioma","volume":"16","author":"Cedr\u00e9s","year":"2014","journal-title":"Clin. Transl Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e1002404","DOI":"10.1371\/journal.pgen.1002404","article-title":"Acute Multiple Organ Failure in Adult Mice Deleted for the Developmental Regulator Wt1","volume":"7","author":"Chau","year":"2011","journal-title":"Plos Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.tig.2012.04.004","article-title":"The Role of Wt1 in Regulating Mesenchyme in Cancer, Development, and Tissue Homeostasis","volume":"28","author":"Chau","year":"2012","journal-title":"Trends Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJMoa1813599","article-title":"Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis","volume":"381","author":"Chen","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1038\/onc.2014.431","article-title":"Erratum: Tumor Hypoxia Induces Nuclear Paraspeckle Formation through HIF-2\u03b1 Dependent Transcriptional Activation of NEAT1 Leading to Cancer Cell Survival","volume":"34","author":"Choudhry","year":"2015","journal-title":"Oncogene"},{"key":"B19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/IGC.0b013e318207cab5","article-title":"Wilms Tumor Gene 1(WT1) Is a Prognostic Marker in High-Grade Uterine Sarcoma","volume":"21","author":"Coosemans","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of Chronic Kidney Disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1182\/blood-2005-07-2889","article-title":"Wilms Tumor Suppressor, Wt1, Is a Transcriptional Activator of the Erythropoietin Gene","volume":"107","author":"Dame","year":"2006","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/hmg\/ddh015","article-title":"Development of an siRNA-Based Method for Repressing Specific Genes in Renal Organ Culture and its Use to Show that the Wt1 Tumour Suppressor Is Required for Nephron Differentiation","volume":"13","author":"Davies","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.leukres.2010.10.020","article-title":"Hypoxia-inducible Factor-1\u03b1 Protein Expression Is Associated with Poor Survival in normal Karyotype Adult Acute Myeloid Leukemia","volume":"35","author":"Deeb","year":"2011","journal-title":"Leuk. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07357900802574710","article-title":"Development and Validation of Gene Expression Profile Signatures in Early-Stage Breast Cancer","volume":"27","author":"Desmedt","year":"2009","journal-title":"Cancer Invest."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia","volume":"355","author":"Dr\u00fceke","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2215\/CJN.00630208","article-title":"Health-related Quality of Life and Hemoglobin Levels in Chronic Kidney Disease Patients","volume":"4","author":"Finkelstein","year":"2009","journal-title":"Cjasn"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1038\/leu.2015.102","article-title":"Hypoxia Inducible Factor (HIF)-2\u03b1 Accelerates Disease Progression in Mouse Models of Leukemia and Lymphoma but Is Not a Poor Prognosis Factor in Human AML","volume":"29","author":"Forristal","year":"2015","journal-title":"Leukemia"},{"key":"B28","doi-asserted-by":"publisher","first-page":"858","DOI":"10.4161\/cbt.20838","article-title":"Regulation of HIF-1\u03b1 Signaling and Chemoresistance in Acute Lymphocytic Leukemia under Hypoxic Conditions of the Bone Marrow Microenvironment","volume":"13","author":"Frolova","year":"2012","journal-title":"Cancer Biol. Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/sj.leu.2404918","article-title":"Vorinostat and Bortezomib Significantly Inhibit WT1 Gene Expression in MO7-e and P39 Cell Lines","volume":"22","author":"Galimberti","year":"2008","journal-title":"Leukemia"},{"key":"B30","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3390\/ijms21030725","article-title":"The Influence of Inflammation on Anemia in CKD Patients","volume":"21","author":"Gluba-Brz\u00f3zka","year":"2020","journal-title":"Ijms"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1245\/s10434-012-2838-9","article-title":"Wilms' Tumor 1 Protein and Estrogen Receptor Beta Expression Are Associated with Poor Outcomes in Uterine Carcinosarcoma","volume":"20","author":"Guntupalli","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.kisu.2020.12.002","article-title":"Hypoxia-inducible Factor-Prolyl Hydroxylase Inhibitors in the Treatment of Anemia of Chronic Kidney Disease","volume":"11","author":"Haase","year":"2021","journal-title":"Kidney Int. Supplements"},{"key":"B33","doi-asserted-by":"publisher","first-page":"9618","DOI":"10.1073\/pnas.88.21.9618","article-title":"Alternative Splicing and Genomic Structure of the Wilms Tumor Gene WT1","volume":"88","author":"Haber","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B34","doi-asserted-by":"publisher","first-page":"6933","DOI":"10.1038\/sj.onc.1207609","article-title":"Transcriptional Activation of C-Myc Proto-Oncogene by WT1 Protein","volume":"23","author":"Han","year":"2004","journal-title":"Oncogene"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1080\/15384101.2020.1817666","article-title":"Wilms' Tumor 1 (WT1) Promotes Ovarian Cancer Progression by Regulating E-Cadherin and ERK1\/2 Signaling","volume":"19","author":"Han","year":"2020","journal-title":"Cell Cycle"},{"key":"B36","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1042\/BST0360629","article-title":"The Role of the Wilms' Tumour-Suppressor Protein WT1 in Apoptosis","volume":"36","author":"Hartkamp","year":"2008","journal-title":"Biochem. Soc. Trans."},{"key":"B37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3109\/07357907.2011.633291","article-title":"Low Wilms' Tumor Gene Expression in Tumor Tissues Predicts Poor Prognosis in Patients with Non-small-cell Lung Cancer","volume":"30","author":"Hayashi","year":"2012","journal-title":"Cancer Invest."},{"key":"B38","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/s0960-9822(99)80369-8","article-title":"The Wilms Tumor Suppressor Gene Wt1 Is Required for Development of the Spleen","volume":"9","author":"Herzer","year":"1999","journal-title":"Curr. Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","article-title":"Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects","volume":"93","author":"Hockel","year":"2001","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"B40","doi-asserted-by":"publisher","first-page":"R196","DOI":"10.1093\/hmg\/ddl196","article-title":"The many Facets of the Wilms' Tumour Gene, WT1","volume":"15","author":"Hohenstein","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"B41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/ckj\/sfy013","article-title":"Daprodustat for Anemia: a 24-week, Open-Label, Randomized Controlled Trial in Participants with Chronic Kidney Disease","volume":"12","author":"Holdstock","year":"2019","journal-title":"Clin. Kidney J."},{"key":"B42","first-page":"997","article-title":"Evidence for WT1 as a Wilms Tumor (WT) Gene: Intragenic Germinal Deletion in Bilateral WT","volume":"48","author":"Huff","year":"1991","journal-title":"Am. J. Hum. Genet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrc3002","article-title":"Wilms' Tumours: about Tumour Suppressor Genes, an Oncogene and a Chameleon Gene","volume":"11","author":"Huff","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"B44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ygyno.2005.09.052","article-title":"Expression of Wilms Tumor Gene (WT1) in Epithelial Ovarian Cancer","volume":"101","author":"Hylander","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ydbio.2007.09.014","article-title":"Wt1 and Retinoic Acid Signaling Are Essential for Stellate Cell Development and Liver Morphogenesis","volume":"312","author":"Ijpenberg","year":"2007","journal-title":"Dev. Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.1038\/s41380-020-0759-8","article-title":"Brain-specific Wt1 Deletion Leads to Depressive-like Behaviors in Mice via the Recruitment of Tet2 to Modulate Epo Expression","volume":"26","author":"Ji","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"B47","doi-asserted-by":"publisher","first-page":"6683","DOI":"10.1158\/0008-5472.CAN-06-0425","article-title":"Direct Transcriptional Up-Regulation of Cyclooxygenase-2 by Hypoxia-Inducible Factor (HIF)-1 Promotes Colorectal Tumor Cell Survival and Enhances HIF-1 Transcriptional Activity during Hypoxia","volume":"66","author":"Kaidi","year":"2006","journal-title":"Cancer Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1182\/blood-2010-02-270322","article-title":"Hepatic HIF-2 Regulates Erythropoietic Responses to Hypoxia in Renal Anemia","volume":"116","author":"Kapitsinou","year":"2010","journal-title":"Blood"},{"key":"B49","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/s1357-2725(03)00211-5","article-title":"The Mammalian Basic helix-loop-helix\/PAS Family of Transcriptional Regulators","volume":"36","author":"Kewley","year":"2004","journal-title":"Int. J. Biochem. Cel Biol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1172\/JCI83551","article-title":"Distinct Subpopulations of FOXD1 Stroma-Derived Cells Regulate Renal Erythropoietin","volume":"126","author":"Kobayashi","year":"2016","journal-title":"J. Clin. Invest."},{"key":"B51","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ijc.11721","article-title":"WT1 Is a Tumor-Associated Antigen in colon Cancer that Can Be Recognized Byin Vitro Stimulated Cytotoxic T Cells","volume":"109","author":"Koesters","year":"2004","journal-title":"Int. J. Cancer"},{"key":"B52","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/0092-8674(93)90515-r","article-title":"WT-1 Is Required for Early Kidney Development","volume":"74","author":"Kreidberg","year":"1993","journal-title":"Cell"},{"key":"B53","doi-asserted-by":"publisher","first-page":"443","DOI":"10.2147\/CMAR.S232294","article-title":"LncRNA WT1-AS Downregulates Survivin by Upregulating miR-203 in Papillary Thyroid Carcinoma","volume":"12","author":"Le","year":"2020","journal-title":"Cmar"},{"key":"B54","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3390\/jcm7120493","article-title":"The Number of Comorbidities Predicts Renal Outcomes in Patients with Stage 3-5 Chronic Kidney Disease","volume":"7","author":"Lee","year":"2018","journal-title":"Jcm"},{"key":"B55","doi-asserted-by":"publisher","first-page":"845","DOI":"10.2215\/CJN.06450710","article-title":"Darbepoetin Alfa Impact on Health Status in Diabetes Patients with Kidney Disease: a Randomized Trial","volume":"6","author":"Lewis","year":"2011","journal-title":"Cjasn"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1111\/jcmm.14813","article-title":"Deubiquitinase Inhibitor Degrasyn Suppresses Metastasis by Targeting USP5\u2010WT1\u2010E\u2010cadherin Signalling Pathway in Pancreatic Ductal Adenocarcinoma","volume":"24","author":"Li","year":"2020","journal-title":"J. Cel Mol Med"},{"key":"B57","first-page":"921","article-title":"Wilms' Tumor Suppressor Gene (WT1) Is Expressed in Primary Breast Tumors Despite Tumor-specific Promoter Methylation","volume":"61","author":"Loeb","year":"2001","journal-title":"Cancer Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"5100","DOI":"10.1073\/pnas.90.11.5100","article-title":"Physical and Functional Interaction between WT1 and P53 Proteins","volume":"90","author":"Maheswaran","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B59","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/ng.494","article-title":"Wt1 Is Required for Cardiovascular Progenitor Cell Formation through Transcriptional Control of Snail and E-Cadherin","volume":"42","author":"Mart\u00ednez-Estrada","year":"2010","journal-title":"Nat. Genet."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/s41416-018-0317-1","article-title":"WT1 Expression in Vessels Varies with Histopathological Grade in Tumour-Bearing and Control Tissue from Patients with Breast Cancer","volume":"119","author":"McGregor","year":"2018","journal-title":"Br. J. Cancer"},{"key":"B61","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/s0074-7696(08)60418-0","article-title":"The Wilms' Tumor 1 Gene: Oncogene or Tumor Suppressor Gene?","volume":"181","author":"Menke","year":"1998","journal-title":"Int. Rev. Cytol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.humpath.2019.02.002","article-title":"Co-expression of Cytokeratin and Vimentin in Colorectal Cancer Highlights a Subset of Tumor Buds and an Atypical Cancer-Associated Stroma","volume":"87","author":"Meyer","year":"2019","journal-title":"Hum. Pathol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1242\/dev.126.9.1845","article-title":"YAC Complementation Shows a Requirement for Wt1 in the Development of Epicardium, Adrenal Gland and throughout Nephrogenesis","volume":"126","author":"Moore","year":"1999","journal-title":"Development"},{"key":"B64","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/hon.2834","article-title":"Upregulated Hypoxia Inducible Factor 1\u03b1 Signaling Pathway in High Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Is Associated with Better Response to 5\u2010azacytidine-Data from the Hellenic Myelodysplastic Syndrome Study Group","volume":"39","author":"Mpakou","year":"2021","journal-title":"Hematological Oncol."},{"key":"B65","first-page":"1333","article-title":"Correlation of Wilms' Tumor 1 Isoforms with HER2 and ER-\u03b1 and its Oncogenic Role in Breast Cancer","volume":"34","author":"Nasomyon","year":"2014","journal-title":"Anticancer Res."},{"key":"B66","first-page":"2416","article-title":"Growth Inhibition of Breast Cancer Cell Line MCF-7 by siRNA Silencing of Wilms Tumor 1 Gene","volume":"90","author":"Navakanit","year":"2007","journal-title":"J. Med. Assoc. Thai"},{"key":"B67","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/ijc.10476","article-title":"Overexpression of the Wilms' Tumor geneWT1 Inde Novo Lung Cancers","volume":"100","author":"Oji","year":"2002","journal-title":"Int. J. Cancer"},{"key":"B68","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1159\/000481353","article-title":"Wilms' Tumor Gene 1 (WT1) Peptide Vaccine Therapy for Hematological Malignancies: From CTL Epitope Identification to Recent Progress in Clinical Studies Including a Cure-Oriented Strategy","volume":"40","author":"Oka","year":"2017","journal-title":"Oncol. Res. Treat."},{"key":"B69","doi-asserted-by":"publisher","first-page":"13885","DOI":"10.1073\/pnas.0405884101","article-title":"Induction of WT1 (Wilms' Tumor Gene)-specific Cytotoxic T Lymphocytes by WT1 Peptide Vaccine and the Resultant Cancer Regression","volume":"101","author":"Oka","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B70","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/(sici)1097-0215(19970807)72:4<696::aid-ijc23>3.0.co;2-8","article-title":"WT1 Contributes to Leukemogenesis: Expression Patterns in 7,12-dimethylbenz[a]anthracene (DMBA)-induced Leukemia","volume":"72","author":"Osaka","year":"1997","journal-title":"Int. J. Cancer"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.kint.2016.07.019","article-title":"Vadadustat, a Novel Oral HIF Stabilizer, Provides Effective Anemia Treatment in Nondialysis-dependent Chronic Kidney Disease","volume":"90","author":"Pergola","year":"2016","journal-title":"Kidney Int."},{"key":"B72","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s12253-016-0181-3","article-title":"Turning Back the Wheel: Inducing Mesenchymal to Epithelial Transition via Wilms Tumor 1 Knockdown in Human Mesothelioma Cell Lines to Influence Proliferation, Invasiveness, and Chemotaxis","volume":"23","author":"Pl\u00f6nes","year":"2017","journal-title":"Pathol. Oncol. Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1053\/j.ajkd.2015.12.020","article-title":"Roxadustat (FG-4592) versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study","volume":"67","author":"Provenzano","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1172\/JCI30117","article-title":"Hypoxia-inducible Factor-2 (HIF-2) Regulates Hepatic Erythropoietin In Vivo","volume":"117","author":"Rankin","year":"2007","journal-title":"J. Clin. Invest."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/sj.leu.2402988","article-title":"WT1 in Acute Leukemia, Chronic Myelogenous Leukemia and Myelodysplastic Syndrome: Therapeutic Potential of WT1 Targeted Therapies","volume":"17","author":"Rosenfeld","year":"2003","journal-title":"Leukemia"},{"key":"B76","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00424-008-0621-3","article-title":"Role of the Wilms' Tumour Transcription Factor, Wt1, in Blood Vessel Formation","volume":"458","author":"Scholz","year":"2009","journal-title":"Pflugers Arch. - Eur. J. Physiol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1146\/annurev.cellbio.15.1.551","article-title":"Regulation of Mammalian O2 Homeostasis by Hypoxia-Inducible Factor 1","volume":"15","author":"Semenza","year":"1999","journal-title":"Annu. Rev. Cel Dev. Biol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.ejca.2008.01.008","article-title":"Wilms' Tumour 1 Gene Expression Is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis","volume":"44","author":"Sera","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e0236132","DOI":"10.1371\/journal.pone.0236132","article-title":"Prevalence of Anemia in Patients with Chronic Kidney Disease in Japan: A Nationwide, Cross-Sectional Cohort Study Using Data from the Japan Chronic Kidney Disease Database (J-CKD-DB)","volume":"15","author":"Sofue","year":"2020","journal-title":"PLoS One"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1056\/NEJMoa1005109","article-title":"Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes","volume":"363","author":"Solomon","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"e84943","DOI":"10.1371\/journal.pone.0084943","article-title":"Prevalence of Anemia in Chronic Kidney Disease in the United States","volume":"9","author":"Stauffer","year":"2014","journal-title":"PLoS One"},{"key":"B82","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/00000441-198809000-00005","article-title":"Treatment of the Anemia of Predialysis Patients with Recombinant Human Erythropoietin: a Randomized, Placebo-Controlled Trial","volume":"296","author":"Stone","year":"1988","journal-title":"Am. J. Med. Sci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/ki.2008.295","article-title":"Secondary Analysis of the CHOIR Trial Epoetin-\u03b1 Dose and Achieved Hemoglobin Outcomes","volume":"74","author":"Szczech","year":"2008","journal-title":"Kidney Int."},{"key":"B84","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/s0002-9440(10)64554-3","article-title":"The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1\u03b1 and HIF-2\u03b1 in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages","volume":"157","author":"Talks","year":"2000","journal-title":"Am. J. Pathol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/sj.onc.1208345","article-title":"HER2\/neu Increases the Expression of Wilms' Tumor 1 (WT1) Protein to Stimulate S-phase Proliferation and Inhibit Apoptosis in Breast Cancer Cells","volume":"24","author":"Tuna","year":"2005","journal-title":"Oncogene"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1096\/fj.02-1065fje","article-title":"Oxygen\u2010regulated Expression of the Wilms' Tumor suppressorWt1involves Hypoxia\u2010inducible Factor\u20101 (HIF\u20101)","volume":"17","author":"Wagner","year":"2003","journal-title":"FASEB j."},{"key":"B87","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1038\/sj.onc.1211044","article-title":"The Wilms' Tumour Suppressor WT1 Is Involved in Endothelial Cell Proliferation and Migration: Expression in Tumour Vessels In Vivo","volume":"27","author":"Wagner","year":"2008","journal-title":"Oncogene"},{"key":"B88","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/1475-2867-13-114","article-title":"Wilms' Tumour Suppressor Gene 1 (WT1) Is Involved in the Carcinogenesis of Lung Cancer through Interaction with PI3K\/Akt Pathway","volume":"13","author":"Wang","year":"2013","journal-title":"Cancer Cel Int"},{"key":"B89","doi-asserted-by":"publisher","first-page":"re12","DOI":"10.1126\/stke.3062005re12","article-title":"Integration of Oxygen Signaling at the Consensus HRE","volume":"2005","author":"Wenger","year":"2005","journal-title":"Sci. STKE"},{"key":"B90","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ar.a.10129","article-title":"The Epicardium and Epicardially Derived Cells (EPDCs) as Cardiac Stem Cells","author":"Wessels","year":"2004","journal-title":"Anat. Rec."},{"key":"B91","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00428-007-0433-4","article-title":"Clinicopathological Significance of WT1 Expression in Ovarian Cancer: a Possible Accelerator of Tumor Progression in Serous Adenocarcinoma","volume":"451","author":"Yamamoto","year":"2007","journal-title":"Virchows Arch."},{"key":"B92","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13046-016-0298-y","article-title":"HIF-2\u03b1 Promotes Epithelial-Mesenchymal Transition through Regulating Twist2 Binding to the Promoter of E-Cadherin in Pancreatic Cancer","volume":"35","author":"Yang","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/sj.leu.2404624","article-title":"A Tumor Suppressor and Oncogene: the WT1 story","volume":"21","author":"Yang","year":"2007","journal-title":"Leukemia"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1158\/0008-5472.CAN-10-2360","article-title":"HIF-1\u03b1 Confers Aggressive Malignant Traits on Human Tumor Cells Independent of its Canonical Transcriptional Function","volume":"71","author":"Yoo","year":"2011","journal-title":"Cancer Res."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1182\/blood-2011-10-387381","article-title":"HIF1\u03b1 Is Required for Survival Maintenance of Chronic Myeloid Leukemia Stem Cells","volume":"119","author":"Zhang","year":"2012","journal-title":"Blood"},{"key":"B96","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/modpathol.3800264","article-title":"PDGF-A, PDGF-R\u03b2, TGF\u03b23 and Bone Morphogenic Protein-4 in Desmoplastic Small Round Cell Tumors with EWS-WT1 Gene Fusion Product and Their Role in Stromal Desmoplasia: an Immunohistochemical Study","volume":"18","author":"Zhang","year":"2005","journal-title":"Mod. Pathol."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.876723\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T06:20:12Z","timestamp":1649226012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.876723\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,6]]},"references-count":96,"alternative-id":["10.3389\/fcell.2022.876723"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2022.876723","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,6]]},"article-number":"876723"}}